5 recruiting, 4 completed, 3 not yet recruiting, 2 unknown. 3 Not applicable, 3 Phase 2, 3 Phase 4, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Recruiting 2, Not yet recruiting 1 |
| Phase 2 | 3 | Completed 2, Recruiting 1 |
| Phase 4 | 3 | Completed 1, Recruiting 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Cirrhoses, Liver: new trials by email Literature Review of Cirrhoses, Liver trials Research Report on Cirrhoses, Liver
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Application of Lifestyle Enhancing Validated Integrative Therapies for Everyday Pain in Cirrhosis High-touch self-management program, Low-touch self-management program - Cirrhoses, Liver | Not applicable | Not yet recruiting | University of Pennsylvania | 625 | 2027-01-01 | 2026-10-02 |
| Detecting Liver Fibrosis in Patients At-risk Routine study procedure - Fatty Liver, NAFLD - Non-Alcoholic Fatty Liver Disease | Not yet recruiting | Helse Stavanger HF | 1200 | 2026-08-01 | 2026-08-20 | |
| ProspEXPO : Study of the Associations Between Hepatocellular Carcinoma and Chemical and Psychosocial Environmental EXPOsome Blood, urine and stool biocollection - Cirrhoses, Liver, Carcinoma Liver | Not applicable | Recruiting | University Hospital, Angers | 300 | 2025-12-17 | 2026-06-10 |
| Evaluating the Efficacy of Vonoprazan in Preventing Post-Endoscopic Variceal Band Ligation Ulcers: A Randomized Controlled Trial Vonoprazan 20 mg, Placebo - Cirrhoses, Liver | Phase 2 | Recruiting | King Edward Medical University | 154 | 2025-12-16 | 2025-12-26 |
| Appropriate Management of Hepatic EncePhalopaThy AmonG cirrhOtic patieNts Admitted to Internal Medicine Cirrhoses, Liver, Portal Hypertension Related to Cirrhosis | Active not recruiting | Fadoi Foundation, Italy | 400 | 2025-12-05 | 2026-07-27 | |
| Nursing Needs of Patients With Cirrhosis blood sample, blood samples for analysis of cirrhosis - Cirrhoses, Liver | Enrolling by invitation | Landspitali University Hospital | 150 | 2025-11-17 | 2025-12-09 | |
| Laparoscopic Partial Splenectomy for Hypersplenism in Liver Cirrhosis Patients Laparoscopic Partial Splenectomy - Cirrhoses, Liver, Splenectomy; Status | Not applicable | Recruiting | Northern Jiangsu People's Hospital | 30 | 2025-09-24 | 2025-10-03 |
| Role of Allopurinol in Prevention of Complications Related to Decompensated Cirrhosis of Liver Allopurinol Tablet, Placebo - Cirrhoses, Liver, Decompensated Cirrhosis of Liver | Phase 4 | Recruiting | Bangladesh Medical University | 54 | 2025-09-10 | 2026-09-02 |
| Study on Proteomic and Microbiome Changes in Patients With Hepatic Encephalopathy (HE) Cirrhoses, Liver, Hepatic Encephalopathy (HE) | Not yet recruiting | The First Affiliated Hospital with Nanjing Medical University | 32 | 2025-09-01 | 2025-09-25 | |
| Allopurinol and Pathogenesis of Cirrhosis Allopurinol Tablet, Placebo - Cirrhoses, Liver | Phase 1 / Phase 2 | Completed | Tanta University | 110 | 2023-06-01 | 2026-10-19 |
| Clinical Outcomes in Patients Presenting With Acute Variceal Bleeding Portal Hypertension Related to Cirrhosis, Variceal Bleeding | Completed | Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor | 149 | 2023-01-01 | 2026-10-13 | |
| Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis No Interventions - Cancer Diagnosis, Liver Cancer, Adult | Recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 600 | 2022-09-01 | 2025-04-24 | |
| Comparative Study of Secondary Prophylaxis for SBP Norfloxacin 400 MG, Nitazoxanide 500 MG, Colistin - Spontaneous Bacterial Peritonitis, Cirrhoses, Liver | Phase 4 | Completed | Tanta University | 90 | 2021-03-01 | 2025-02-14 |
| Beta-blockers for Oesophageal Varices Carvedilol - Cirrhoses, Liver, Oesophageal Varices | Phase 4 | Unknown | King's College Hospital NHS Trust | 1200 | 2019-06-17 | 2019-10-03 |
| Open-Label Efficacy and Safety Study of the Elbasvir/ Grazoprevir Fixed Dose Combination Patients With Chronic HCV GT1b Elbasvir/ Grazoprevir 50/100 mg fixed dose combination - Chronic Hepatitis C Genotype 1B, Metabolic Syndrome | Phase 3 | Unknown | Institute Of Cardiology & Internal Diseases, Kazakhstan | 60 | 2017-10-01 | 2017-08-07 |
| Simvastatin Plus Rifaximin in Decompensated Cirrhosis Simvastatin 20 mg, Simvastatin 40mg, Rifaximin 400 mg - Cirrhoses, Liver | Phase 2 | Completed | Judit Pich | 44 | 2017-07-26 | 2019-03-28 |
Fibrosis (6) · Carcinoma, Hepatocellular (2) · Esophageal and Gastric Varices (2) · Hepatic Encephalopathy (2) · Hypertension, Portal (2) · Liver Cirrhosis (2) · Agnosia (1) · Ascites (1) · Chronic Pain (1) · Colorectal Neoplasms (1) · Esophageal Neoplasms (1) · Esophagitis (1) · Fatty Liver (1) · Hepatitis C (1) · Liver Diseases (1)
Digestive System Diseases (9) · Pathologic Processes (9) · Pathological Conditions, Signs and Symptoms (9) · Liver Diseases (8) · Esophageal Diseases (3) · Gastrointestinal Diseases (3) · Metabolic Diseases (3) · Nervous System Diseases (3) · Nutritional and Metabolic Diseases (3) · Adenocarcinoma (2) · Brain Diseases (2) · Brain Diseases, Metabolic (2) · Carcinoma (2) · Central Nervous System Diseases (2) · Digestive System Neoplasms (2)
Allopurinol (2) · Blood Specimen Collection (2) · 1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine (1) · Carvedilol (1) · Colistin (1) · Interviews as Topic (1) · Norfloxacin (1) · Rifaximin (1) · Simvastatin (1) · Urination (1) · elbasvir (1) · grazoprevir (1) · nitazoxanide (1)
Tanta University (2) · Bangladesh Medical University (1) · Fadoi Foundation, Italy (1) · Helse Stavanger HF (1) · Institute Of Cardiology & Internal Diseases, Kazakhstan (1) · Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor (1) · Judit Pich (1) · King Edward Medical University (1) · King's College Hospital NHS Trust (1) · Landspitali University Hospital (1) · Northern Jiangsu People's Hospital (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · The First Affiliated Hospital with Nanjing Medical University (1) · University Hospital, Angers (1) · University of Pennsylvania (1)
China (3) · Egypt (2) · France (2) · Italy (2) · United Kingdom (2) · Bangladesh (1) · Germany (1) · Iceland (1) · Kazakhstan (1) · Netherlands (1) · Norway (1) · Pakistan (1) · Romania (1) · Spain (1) · United States (1)
Andrada Seicean, professor (1) · Ben Carter, BSc, PhD (1) · Guo-Qing Jiang (1) · Kefeng Ding, MD (1) · Mark McPhail, BSc, PhD, MB ChB (1) · Wenfang Cheng (1)
PMID 15915461, PMID 17241381, PMID 27773614, PMID 28690175, PMID 29485654, PMID 29628281, PMID 30367459, PMID 31028350, PMID 31607677, PMID 35793659, PMID 36208844, PMID 36626630, PMID 36765616, PMID 37170239, PMID 37199193, PMID 37364790, PMID 37776622, PMID 37832758, PMID 40348497, PMID 40436647, PMID 40615853
2016 (1)